list of glp 1 agonist drugs GLP-1 Receptor Agonists for Diabetes & Weight Loss glp-1 agonist medications list Holding

Byetta was a twice-daily subcutaneous injectable medication approved for type 2 diabetes

This research highlights the role of glucagon-like peptide-1 receptor agonists in reducing inflammation and oxidative stress, thereby contributing to their therapeutic efficacy in metabolic and cardiovascular conditions. 6

These combined effects make GLP-1 therapy a comprehensive tool for anyone looking to reduce the health risks associated with obesity and improve their long-term quality of life

In 2026, the options have expanded beyond simple injections to include highly effective oral tablets

Single GLP-1 receptor agonists act on one incretin pathway, while dual GIP/GLP-1 agonists target two pathways

Based on this, GLP-1 medications are broadly categorized into: Single GLP-1 Receptor Agonists GLP-1 Receptor Agonists (or GLP-1 RAs) activate and bind to the same receptors in the gut, pancreas and the brain that the natural GLP-1 hormone acts on